Navigation Links
FDA to Extend Review of Data Quality Submission for Genasense(R) in Melanoma
Date:12/21/2007

BERKELEY HEIGHTS, N.J., Dec. 21 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA) announced today that the Company has received notice from the Food and Drug Administration (FDA) that FDA has extended its review period of Genta's request for correction of certain information that was filed pursuant to the Information Quality Act for an additional 60 days. The requested correction relates to FDA's assessment of progression-free survival (PFS) in the Phase 3 trial of Genasense(R) (oblimersen sodium injection) that was presented to the Oncology Drug Advisory Committee (ODAC) that considered Genta's New Drug Application for Genasense in patients with advanced melanoma.

"Melanoma is a key indication in our current Phase 3 development program", said Dr. Loretta M. Itri, M.D., Genta's President for Pharmaceutical Development and Chief Medical Officer. "A methodological error may have impacted ODAC deliberations, which voted unanimously that an improvement in PFS of some magnitude represents clinical benefit that could support regular approval in advanced melanoma."

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its DNA/RNA Medicines program. Genta is currently recruiting patients to the AGENDA Trial, a global Phase 3 trial of Genasense in patients with advanced melanoma. The leading drug in Genta's Small Molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusivel
'/>"/>

SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
2. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
3. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
4. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
5. New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV
6. UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets
7. CSL Behring Study in Animal Models Shows Feasibility of Developing a Half-Life Extended Recombinant FVIIa that Retains Biologic Activity
8. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
9. ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
10. GlaxoSmithKline Accelerates Review of Exelixis XL880
11. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015 New exchange plan ... of 2015 compared to the same time a year ... Scripts (NASDAQ: ESRX ) Exchange Pulse™ report, released ... of 2014, the number of new exchange plan enrollees ... percent in the first quarter of 2015. However, when ...
(Date:6/30/2015)... July 1, 2015 Ansell, a ... the winners of the first Ansell Cares ® ... (O.R.) Nurses. The 2015 award, organised in partnership with ... nurses who display exceptional skill and quality in patient ... and development. Award ceremonies are taking place today in ...
(Date:6/30/2015)... , June 30, 2015  A new way for ... for their own health and first aid, is being introduced ... This campaign has a funding goal of $70,000, which needs ... and first aid bracelet to market. This device was inspired ... and the fact that emergencies occur every day. While medical ...
Breaking Medicine Technology:Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 2Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 3Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 5Ansell Announces European O.R. Nurse Hero Award Winners 2Ansell Announces European O.R. Nurse Hero Award Winners 3Amyko Propels Medical Alert Bracelets Into the Modern Era 2
... 2012 Medical Alarm Concepts Holding, Inc. (OTCQB: MDHI.PK), ... system that allows the user to speak and listen ... for this week,s media test.   The ... Inspirational TV, Fox News Channel, and MSNBC. The spot ...
... today releases further intriguing insights uncovered by its ,Face ... five surveyed European women think that it,s ,the norm, to ... and laser treatments to maintain their looks as they grow ... Hollywood elite, two thirds of the respondents admit that they ...
Cached Medicine Technology:Medical Alarm Concepts and Harrington Media Announce Final Schedule for MediPendant™ Nationwide Television Test Launch 2The Changing Face of Beauty 2The Changing Face of Beauty 3The Changing Face of Beauty 4The Changing Face of Beauty 5
(Date:7/1/2015)... NC (PRWEB) , ... July 01, 2015 , ... ... 2013 mesothelioma compensation law has just published a top ten list they hope ... the report. Click here to read it now. , More ...
(Date:7/1/2015)... ... ... Author Francesca Camp wasn’t always a steadfast supporter of plastic surgery. But just ... of the practice; a terrible car accident years ago left her injured and in need ... It ? (And What if I Do?): Answers to All Your Questions about Plastic Surgery” ...
(Date:7/1/2015)... ... 01, 2015 , ... After conducting a nationwide executive ... Medical Center in Oceanside, Calif., has hired Cheryle Bernard-Shaw as chief compliance ... adaptation efforts and growing a focus on risk management, Bernard-Shaw will assume her ...
(Date:7/1/2015)... ... , ... Incentivizing the use of generic drugs has been an easy way ... or 90% off the prices for the brand-name products. But now that generics are ... impact of these high-cost generic drugs. The July issue of Atlantic Information Services, Inc.’s ...
(Date:7/1/2015)... ... July 01, 2015 , ... Northbound ... as Director of Referral Relations. , Emily originally entered the behavioral healthcare ... designed and implemented unique academic curriculum for clients to engage in their educational ...
Breaking Medicine News(10 mins):Health News:New Report Identifies Top 10 Mesothelioma Research Priorities, According to Surviving Mesothelioma 2Health News:Francesca Camp’s New Book Unmasks Plastic Surgery Advice 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 3Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 2Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 3Health News:Northbound Treatment Services Welcomes Emily Orrick as Director of Referral Relations 2
... to physicians shows that doctors are most influenced by ... drugs with many side effects, according to the Management ... the flagship journal of the Institute for Operations Research ... regular feature of the journal, is a digest of ...
... -- Mayo Clinic researchers today presented results of ... -- a first step therapy designed to reduce ... dexamethasone (Cybor-D) showing an improved response over the ... by Craig B. Reeder, M.D., at the American ...
... of heart disease, NORTHRIDGE, Calif., Dec. 10 ... in the U.S. -- claiming one life every 35,seconds(1). ... conducted by Harris Interactive and commissioned by Nature Made(R),confirms ... fact, the,survey found nearly half of all respondents did ...
... Makes It Easy to Give Emotional Support and Show Gratitude to ... Our Injured Service Members, ... and meaningful to get into the holiday spirit, here,s a great item,for ... been,wounded in military service that you appreciate (and haven,t forgotten) his,or her ...
... is known to be associated with cancer yet too ... disorder, according to researchers from the Indiana University School ... Medical Center. , In a study published ... Caroline Carney Doebbeling, M.D., M.Sc. and Laura Jones, Ph.D., ...
... Philadelphia, PA, December 10, 2007 Psychiatrists remain divided ... and anxiety disorders, the most common mental disorders. Committees ... carve nature at its anxious joints for the fifth ... gold standard reference book for psychiatrists. Only recently has ...
Cached Medicine News:Health News:MDs' reactions to pharma marketing influenced by brand, side effects: Management Insights 2Health News:National Nature Made(R) Survey Finds U.S. Adults Are Concerned About Heart Disease but May not be Managing Their Risk 2Health News:National Nature Made(R) Survey Finds U.S. Adults Are Concerned About Heart Disease but May not be Managing Their Risk 3Health News:Just in Time for the Holidays, The USO and CarePages.com Launch 'Operation: Show You Care' 2Health News:Just in Time for the Holidays, The USO and CarePages.com Launch 'Operation: Show You Care' 3Health News:Depression screening for cancer patients too often falls between the cracks 2Health News:Is there a developmental component to the risk for depression? 2
An enzyme-linked immuno-sorbent assay for the detection and quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
Anti Gliadin IgG Enzyme Immunosay for quantitative determination of Gliadin-IgG antibodies in serum....
... System - A Single Platform for ... with true load-and-go productivity and maximized ... and UF-100 for complete walkaway urinalysis. ... together deliver utmost reliability. Ease of ...
... is one of the 3 major naturally ... estrone). In terms of estrogenic activity, estriol ... Estriol is produced almost exclusively during pregnancy, ... the normal human fetus. During pregnancy, the ...
Medicine Products: